Real-time enrollment status for this epilepsy intractable clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:25 PM UTC
| NCT Number | NCT05406349 |
| Recruiting Status | Recruiting |
| Condition | Epilepsy Intractable |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Boston University Charles River Campus |
| Last Updated on CT.gov | March 14, 2025 (Mar 14, 2025) |
As of July 13, 2026: Clinical trial NCT05406349 is currently recruiting participants. This clinical trial study for epilepsy intractable is actively seeking new participants at 1 location across the United States. The study is sponsored by Boston University Charles River Campus. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05406349 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05406349 was last updated Mar 14, 2025 (March 14, 2025). HelloStudys verifies this status automatically.